26 employees
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
2021
$70M
from 4 investors over 4 rounds
Matchpoint Therapeutics raised $70M on October 14, 2022
Investors: Sanofi Ventures, Digitalis Ventures and Vertex Ventures HC
Matchpoint Therapeutics raised $30M on November 1, 2021
Investors: Atlas Venture